Waltham, MA, March 13, 2012 --(PR.com
)-- The Medical Development Group announces its Wednesday, April 4, 2012 Forum entitled “Pre-clinical Testing: What We Need to Know for Device Development.” Device development demands precise, reproducible animal models with quantifiable metrics. This session will review different scenarios for effectively using pre-clinical testing as a basis for getting regulatory approval for clinical (human) testing. The panel will relate first-hand experiences about possible approaches and changes being considered, including:
- Scenarios for “how to do it right”
- Pitfalls that can occur when pre-clinical testing is done incorrectly
- Using pre-clinical testing to efficiently charter through the regulatory process (FDA, CE mark or FIM (non CE mark)) country approval
Moderator: Dan Howell, PhD, Director of Sales & Marketing, CBSET, Inc.
Keynote Speaker: Adam Groothuis, PhD, VP and COO, CBSET, Inc.
Panelists: Sherry Parker, PhD, Director, Technical and Regulatory, Medical Devices WuXi AppTec, Inc.
Jeffrey R. Scott, PhD, Manager, Preclinical Affairs C.R. Bard, Inc. (Davol)
Event Champions: Joyce College, MBA, RN, Director, Business Development, Automated Medical Instruments
K. Joanne Kalp, Vice President, Product Management, Draeger Monitoring and IT
Link to event details: MDG Wednesday, April 4, 2012 Forum begins 5:30pm – http://www.meddevgroup.org/
Registration Fee: Members: $25 (prepaid), $35 at the door.
Nonmembers: $35 (prepaid); $45 at the door. Cutoff for preregistration is 8 PM the evening before the event.
Location: Foley Hoag Emerging Enterprise Center, Bay Colony Corporate Center, 1000 Winter Street, Suite 4000, North Entrance, Waltham, Massachusetts 02451-1436 See event link for directions: http://www.meddevgroup.org/. Contact: email@example.com